AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 151 min read$NCDL

Vichness Shaul purchased $61K of NCDL (indirect holdings)

Vichness Shaul (Chief Financial Off./Treasurer) purchased 5,000 indirectly-held shares of Nuveen Churchill Direct Lending Corp. (NCDL) at $12.25 on 2026-09-14.

Original reporting
SEC EDGAR · Vichness Shaul
Published Sep 15, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$NCDL
Neutral
high confidence
Mentioned
$NCDL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCDLNeutralLow
01

Why it matters

The CFO's modest purchase adds a small positive signal but is unlikely to influence market pricing.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Insider ownership remains low; the purchase does not change control dynamics.

Relevance 4/10Novelty 4/10Timing: filing date 2026‑09‑15

Background

Form 4 filings disclose insider transactions and are used to gauge insider sentiment.

Company-level read

Ticker impact

$NCDLNeutralHigh confidence
Context

CFO Vichness Shaul bought 5,000 shares of NCDL for $61,250 via an open‑market purchase.

Expected impact

Minimal short‑term price effect; unlikely to move the stock materially.

Evidence & confidence

Form 4 is a primary source; transaction amount is under $100k, typical for routine insider activity.

Market effects

Sector

None; the purchase does not affect the broader BDC sector.

Regional

None; limited to U.S. listed BDC investors.

Global

None

Counterpoint

What could challenge this read

The buy could be a routine portfolio rebalancing rather than a strong endorsement.

Key entities

  • Issuer
    Nuveen Churchill Direct Lending Corp.

    Closed‑end BDC focused on direct lending.

  • Insider
    Vichness Shaul

    Chief Financial Officer / Treasurer of NCDL.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

NCDL insider trading history →

Related articles

NOV 3
$NCDLMed

Nuveen Churchill Direct Lending Corp. Announces Third Quarter 2026 Results

Nuveen Churchill Direct Lending Corp. (NCDL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Nuveen Churchill Direct Lending Corp. Announces Third Quarter 2026 Results Reports Third Quarter Net Investment Income of $0.38 per Share Declares Fourth Quarter Distribution of $0.38 per Share, Consisting of a Regular Distribution of $0.36 per Share and a Supplemental Distributi

SEC EDGAR 8-K2 min
AUG 6
$NCDLMed

NCDL Reports Q2 Net Investment Income of $0.41 Per Share

Nuveen Churchill Direct Lending Corp. (NCDL) reported Q2 2026 net investment income of $0.41 per share and net increase in net assets from operations of $0.07 per share. Investment income was $44.3 million versus $53.1 million a year earlier. It declared a Q3 distribution of $0.38 per share and reported NAV of $17.19 per share.

quiverquant.com6 min
AUG 6
$NCDLMed

Nuveen Churchill Direct Lending Corp. Announces Second Quarter 2026 Results

Nuveen Churchill Direct Lending Corp. (NCDL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Nuveen Churchill Direct Lending Corp. Announces Second Quarter 2026 Results Reports Second Quarter Net Investment Income of $0.41 per Share Declares Third Quarter Distribution of $0.38 per Share, Consisting of a Regular Distribution of $0.36 per Share and a Supplemental Distribut

SEC EDGAR 8-K7 min
NOV 3
$ASPEMedAI 8/10

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $18.0M of ASPE (indirect holdings)

ARCH Venture Fund X, L.P. purchased 1,200,000 indirectly-held shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($18.00M total) on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

SEC EDGAR1 min
NOV 3
$ASPELow

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $2.0M of ASPE

ARCH Venture Fund X, L.P. purchased 133,333 shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($2.00M total) across 2 trades on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

SEC EDGAR1 min